Chest wall irradiation does not impact 10-year survival in intermediate-risk breast cancer

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.

Roche test for accelerating Alzheimer’s diagnosis granted FDA clearance

Dive Brief: Roche received 510(k) clearance for a test that could help cut the time it takes to diagnose Alzheimer’s disease. Currently, physicians diagnose Alzheimer’s by

June 30, 2023

Biogen and Neomorph enter molecular glue degrader deal

The partnership will leverage Neomorph’s molecular glue discovery platform. Credit: PeopleImages.com – Yuri A/Shutterstock. Biogen and Neomorph have entered a research partnership aimed at discovering

November 1, 2024

Australian research links low magnesium levels to increased risk of chronic diseases

A new Australian study has identified why a diet rich in magnesium is so important for our health, reducing the risk of DNA damage and

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.